Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.

Kirtane, Ajay J; Stoler, Robert; Feldman, Robert; Neumann, Franz-Josef; Boutis, Loukas; Tahirkheli, Naeem; Toelg, Ralph; Othman, Islam; Stein, Bernardo; Choi, James W; Windecker, Stephan; Yeh, Robert W; Dauerman, Harold L; Price, Matthew J; Underwood, Paul; Allocco, Dominic; Meredith, Ian; Kereiakes, Dean J (2021). Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent. Circulation. Cardiovascular interventions, 14(3), e010144. American Heart Association 10.1161/CIRCINTERVENTIONS.120.010144

[img] Text
Primary_Results_of_the_EVOLVE.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB)

[Figure: see text].

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1941-7632

Publisher:

American Heart Association

Language:

English

Submitter:

Nadia Biscozzo

Date Deposited:

20 Jan 2022 15:04

Last Modified:

05 Dec 2022 15:59

Publisher DOI:

10.1161/CIRCINTERVENTIONS.120.010144

PubMed ID:

33641374

Uncontrolled Keywords:

aspirin everolimus percutaneous coronary intervention stent thrombosis

BORIS DOI:

10.48350/163219

URI:

https://boris.unibe.ch/id/eprint/163219

Actions (login required)

Edit item Edit item
Provide Feedback